Relationship of radiographic progression status to low disease activity in patients with PsA receiving secukinumab treatment for 2 years
Christopher T. Ritchlin, Philip J. Mease, Corine Gaillez, Laura C. Coates et al.
Journal
Lara D. Veeken
Topics
Spondyloarthritis Studies and Treatments
article
Relationship of radiographic progression status to low disease activity in patients with PsA receiving secukinumab treatment for 2 years
Christopher T. Ritchlin, Philip J. Mease, Corine Gaillez, Laura C. Coates, Alexis Shew, Weibin Bao
article en
Abstract
No abstract available for this paper.
Publication Tag
Lara D. VeekenVol. 65(1)
Institutions
Novartis (Switzerland) (CH), Nuffield Orthopaedic Centre (GB), University of Rochester Medical Center (US), University of Oxford (GB), Swedish Medical Center (US), Tris Pharma (United States) (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Relationship of radiographic progression status to low disease activity in patients with PsA receiving secukinumab treatment for 2 years — Christopher T. Ritchlin, Philip J. Mease, et al. · Lara D. Veeken (2025) | TGRS Research Map | TGRS